Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
KNBIF
Primary Symbol:
V.KNE
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 22, 2024 8:00am
New Press Release - Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the shareholders of the Company held on February 20, 2024, Dr. Robert Huizinga was elected as a director of the...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Feb 15, 2024 3:37pm
RE:RE:Volume baby, volume....
Well RoyMax123...I've been asking/hoping for the same here. When looking at the company presentation on their website, it is making sense not only to wish for the above but to expect the above to
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(202)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Feb 15, 2024 3:08pm
RE:Volume baby, volume....
For most companies 600k is nothing but for Kane I admit that it's interesting. The special meeting is just to vote for the new guy on the board so not too exciting. What I
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Feb 15, 2024 2:12pm
Volume baby, volume....
The last two weeks have been pretty interesting in regards to news and in particular volume of exchange in Vancouver. Over 600K shares traded last week and similar volume this week (and we are
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 31, 2024 9:24am
Revyve - interesting development
The following link includes a demonstration of the spray gel being applied and easily rinsed off with water: https://kanebiotech.com/#videos
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 31, 2024 8:30am
New Press Release - Kane Biotech Files New Patent on revyve(TM) Antimicrobial Wound Gel Spray
Kane will introduce its unique spray gel at the Boswick Burn and Wound Care Symposium WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™ Antimicrobial...
read article.
(16)
•••
babyofbullion
X
View Profile
View Bullboard History
Comment by
babyofbullion
on Jan 26, 2024 1:23pm
RE:RE:Presentation at a symposium in Hawaii
The investment community won't get excited about presentations, they need sales. I'm sure they will come
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Jan 26, 2024 10:32am
RE:Presentation at a symposium in Hawaii
Well, it doesn't look like the investment community is too excited about this upcoming presentation...
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 25, 2024 2:17pm
Presentation at a symposium in Hawaii
It is nice to see some technical sales/presentation activity around the Revyve product. Let's hope that Progenacare are also taking this opportunity to do some PR work. GLTA
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 25, 2024 12:04pm
New Press Release - Kane Biotech to Present its revyve(TM) Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its revyve™ Antimicrobial Wound Gel at the Boswick Burn and Wound Care Symposium. The international...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 25, 2024 11:44am
Latest news release from AnimalcarePLC
Interesting comment from Animalcare PLC regarding the sales of Plaqtiv+, see by yourself; Animalcare PLC 2024 01 25 Press Release
(16)
•••
babyofbullion
X
View Profile
View Bullboard History
Comment by
babyofbullion
on Jan 21, 2024 9:11am
RE:RE:New Press Release - Kane Biotech Announces Special Meeting of Shareholders
Probably not the sole reason for the meeting
(2181)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 18, 2024 10:14pm
RE:New Press Release - Kane Biotech Announces Special Meeting of Shareholders
Waste of money..... Date: January 18, 2024 at 8:12:44PM MST To: rdupuis@kanebiotech.com Subject: Shareholder Comment Hello, I don’t understand the need
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 18, 2024 4:30pm
New Press Release - Kane Biotech Announces Special Meeting of Shareholders
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will hold a special meeting of its shareholders (the “Meeting”) to consider the election of Dr. Robert...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >